SCHEMBL5017426

SCHEMBL5017426

CC(=O)C(c1ccccc1)(c1ccccc1)N1CCN(c2nc3ccccc3s2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 10/20 0.60
▸ NPC1 O15118 10/20 0.60
▸ MAPT P10636 5/20 0.57
▸ LMNA P02545 5/20 0.57
▸ SMN1; SMN2 Q16637 5/20 0.55
▸ ALDH1A1 P00352 3/20 0.55
▸ TSHR P16473 2/20 0.55
▸ HTT P42858 2/20 0.55
▸ ALOX15 P16050 1/20 0.55
▸ CASP1 P29466 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ MAPK1 P28482 1/20 0.55
▸ NPSR1 Q6W5P4 1/20 0.54
▸ TP53 P04637 1/20 0.54
▸ POLB P06746 2/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ CYP2D6 P10635 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ KMT2A Q03164 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18711482 0.78 NPC1 (0.74) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL13153255 0.78 RAB9A (0.65) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL18701805 0.75 NPC1 (1.00) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL6125228 0.73 RAB9A (0.70) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL10219244 0.72 NPC1 (0.72) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL28142588 0.72 RAB9A (0.72) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL2072963 0.72 RAB9A (0.71) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL2202283 0.72 RAB9A (0.69) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL8526236 0.71 RAB9A (0.73) RAB9ANPC1MAPTLMNASMN1; SMN2
SCHEMBL13902467 0.70 RAB9A (0.67) RAB9ANPC1MAPTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1871372-A1 COMBINATION THERAPY COMPRISING AN N-TYPE CALCIUM CHANNEL BLOCKER FOR THE ALLEVIATION OF PAIN Neuromed Pharmaceuticals, Ltd. (CA) 2008-01-02 — — EP disclosed
WO-2006105670-A1 COMBINATION THERAPY COMPRISING AN N-TYPE CALCIUM CHANNEL BLOCKER FOR THE ALLEVIATION OF PAIN NEUROMED PHARMACEUTICALS LTD. (CA) 2006-10-12 — — WO disclosed
Send feedback